Latest ZBH news

Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock

Zacks Investment Research · Thu, 17 Sep 2026 10:41:08 -0400

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zimmer Biomet Announces Americas Leadership Promotions to Accelerate Commercial Transformation

PRNewsWire · Tue, 08 Sep 2026 16:30:00 -0400

Gary Campbell promoted to President, Americas Brian Hatcher promoted to President, Recon, S.E.T., CMFT, Neuro and Biosurgery Bradley Kessler promoted to President, Americas – Robotics, Technology and Data WARSAW, Ind.

Why Is Zimmer (ZBH) Up 1.8% Since Last Earnings Report?

Zacks Investment Research · Fri, 04 Sep 2026 12:37:26 -0400

Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock?

Zimmer Biomet - Showing Signs Of Life

Seeking Alpha · Tue, 01 Sep 2026 09:41:26 -0400

Zimmer Biomet is seeing structural constant currency sales growth appear. This is driven by transformation factors, R&D and M&A efforts. Earnings growth is lagging sales, but this hopefully should catch up soon.

Why Zimmer Biomet (ZBH) is a Top Value Stock for the Long-Term

Zacks Investment Research · Mon, 31 Aug 2026 10:41:08 -0400

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2026

PRNewsWire · Fri, 28 Aug 2026 16:15:00 -0400

WARSAW, Ind., Aug. 28, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the third quarter of 2026.

Is Zimmer Biomet Stock Worth Retaining in Your Portfolio Now?

Zacks Investment Research · Thu, 20 Aug 2026 11:41:03 -0400

ZBH's growth outlook is backed by healthy procedure demand and Z1, HAMMR and OrthoGrid adoption, though debt and competition remain concerns.

Market information is provided for research and visualization and is not investment advice.